Alliar R$674.2 Million Bovespa IPO

Overview:

• Alliar, a medical diagnostics company, went public with a R$674.2 Million ($210.6 Million) IPO on the São Paulo Stock Exchange. 
• This is Brazil's first IPO since June 2015.
• Itau BBA USA Securities, Merrill Lynch Pierce, Fenner & Smith, and Santander Investment Securities acted as placement agents. 
• The shares were priced at R$20.00 per share. 
• The shares were also offered in the US and to non-US persons outside the US. 

Rani Mehta - Journalist